Last updated: August 19, 2025
Introduction
The pharmaceutical identified by NDC 00904-7314 refers to a specific drug product approved by the U.S. Food and Drug Administration (FDA). To accurately assess its market landscape and forecast pricing trajectories, this report examines historical sales data, manufacturing landscape, regulatory considerations, competitive positioning, and emerging market trends. Given the dynamic nature of pharmaceutical markets, economic factors, and healthcare policies, a comprehensive understanding of these parameters is essential for stakeholders, investors, and healthcare providers.
Product Overview
NDC 00904-7314 corresponds to a [specific drug name], which is utilized primarily in [indication]. It is characterized by a [dosage form], with indications spanning [disease states]. The drug’s approval status, patent landscape, and current market exclusivity play critical roles in its market competitiveness.
[Note: Specific drug details should be populated based on the latest FDA database or drug compendiums.]
Market Size and Demand Dynamics
Current Market Landscape
The demand for [drug class / therapeutic area] has been on an upward trajectory, driven by increasing incidence rates, lifespan extension, and expanding indications. According to IQVIA data, the total sales for this therapeutic segment reached approximately \$[latest figure] in the past fiscal year, reflecting a compound annual growth rate (CAGR) of about [X]% over the previous five years [1].
For NDC 00904-7314 specifically, sales data indicates approximately \$[current revenue] in the last fiscal year, with steady growth projected as awareness and diagnosis rates improve.
Competitive Spectrum
Major competitors in the space include [list leading products or generics]. The entry of biosimilars or generics substantially influences pricing and market share. Given patent expiration dates (if any), market entry of biosimilars could erode profitability. Currently, exclusivity status—a key driver for pricing—is active/expired, affecting market dynamics.
Pricing Analysis
Historical Price Trends
Historically, the wholesale acquisition cost (WAC) for NDC 00904-7314 has ranged from \$[initial price] to \$[latest price] per [dosage unit], with annual adjustments influenced by inflation, manufacturing costs, and regulatory factors.
Price Drivers
- Patent and exclusivity status: Patent expiration has resulted in a [decline/stagnation/increase] in price.
- Regulatory changes: New approvals or label expansions can modify pricing strategies.
- Market competition: The entrance of biosimilars or generics typically triggers price erosion.
- Pricing regulations and formulary inclusion: Payer negotiations and formulary placements heavily influence net prices.
Pricing Projections
Based on current market trends and assuming the absence of extraordinary regulatory or patent expirations, preliminary forecasts suggest:
| Year |
Estimated Price per Unit |
Rationale |
| 2023 |
\$[projected] |
Current market rate; inflation adjustment |
| 2024 |
\$[projected] |
Increased competition; potential patent expiry |
| 2025 |
\$[projected] |
Entry of biosimilars or generics; market stabilization |
Between 2024 and 2025, prices are expected to decline by approximately [X]% due to biosimilar entry unless exclusivity is extended or new indications justify premium pricing.
Regulatory and Patent Landscape
The patent status significantly influences pricing strategies:
- Patent Expiry: Scheduled for [date], likely leading to generic or biosimilar competition.
- Regulatory Updates: Pending or recent label expansions may bolster market exclusivity, supporting higher prices.
- Orphan Drug Designation: If applicable, confers exclusivity and allows premium pricing for a defined period.
Regulatory trends favoring value-based pricing and increased transparency may also influence future pricing strategies, especially in managed care settings.
Market Opportunities and Risks
Opportunities
- New Indications: Expansion into additional therapeutic areas could boost demand.
- Formulation Innovations: Development of long-acting or convenience formulations can command higher prices.
- Geographic Expansion: Entering emerging markets offers growth potential.
Risks
- Generic/Biosimilar Competition: Eroding revenues post-patent expiry.
- Regulatory Hurdles: Delays or restrictions could impact market access.
- Pricing Pressures: Payer negotiations and policy shifts toward cost containment may suppress prices.
- Manufacturing Disruptions: Supply chain issues could influence availability, affecting pricing power.
Key Market Trends Shaping Future Pricing
- Shift to Value-Based Pricing: Increasing focus on clinical outcomes over volume.
- Access Constraints: Payer push for rebates and discounts affecting net pricing.
- Emerging Biosimilars: Eroding monotherapy exclusivity and encouraging price competition.
- Patient-Centric Innovations: Favoring formulations that improve adherence, potentially commanding premium prices.
Conclusion and Strategic Recommendations
The trajectory of NDC 00904-7314’s market and pricing is heavily influenced by patent status, market competition, and regulatory developments. While current data suggest stable prices over the immediate future, impending patent expirations demand preparation for price erosion. Stakeholders should monitor patent timelines, reorganize formulary strategies, and evaluate opportunities for indication expansion or formulation innovation.
Proactively engaging in negotiations with payers and investing in value-based pricing models will be vital in maintaining profitability. Additionally, prospective entry into emerging markets could offset domestic price pressures.
Key Takeaways
- Market Size & Demand: Growing, driven by increased therapeutic adoption and expanded indications.
- Pricing Trends: Stable to decreasing; significant shifts anticipated post-patent expiry.
- Competitive Landscape: Increasing biosimilar and generic presence poses downward pressure.
- Regulatory Impact: Patent status and label expansions are critical determinants.
- Strategic Focus: Diversify indications, optimize formulations, and strengthen payer negotiations.
FAQs
-
When is the patent for NDC 00904-7314 expected to expire?
Patent expiration is projected for [specific date], after which biosimilars or generics are likely to enter the market, impacting prices.
-
How do biosimilar entrants influence the pricing of this drug?
Biosimilars typically drive down prices by introducing competition, often resulting in a 20-40% reduction in incumbent drug prices within 1-2 years of market entry.
-
What are the primary factors influencing the future price of NDC 00904-7314?
Patent status, regulatory approvals for new indications, market competition, and healthcare policy changes are the main factors.
-
Are there opportunities for premium pricing through new indications?
Yes. Label expansions into more complex or previously untreatable indications can justify higher pricing.
-
What strategic moves should pharmaceutical companies consider regarding this drug?
Monitoring patent timelines, investing in formulation innovations, exploring expansion into emerging markets, and negotiating value-based contracts are recommended.
References
[1] IQVIA Institute for Human Data Science. The Global Use of Medicine in 2022. IQVIA Reports. 2022.
